Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | +3.70% | +1.82% | -9.68% |
May. 09 | Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M | MT |
Financials (USD)
Sales 2024 * | 173M | Sales 2025 * | 159M | Capitalization | 235M |
---|---|---|---|---|---|
Net income 2024 * | -64M | Net income 2025 * | -73M | EV / Sales 2024 * | 1.36 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.47 x |
P/E ratio 2024 * |
-4.31
x | P/E ratio 2025 * |
-3.43
x | Employees | 167 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.79% |
Latest transcript on Akebia Therapeutics, Inc.
1 day | +3.70% | ||
1 week | +1.82% | ||
1 month | -11.11% | ||
3 months | -29.11% | ||
6 months | +5.66% | ||
Current year | -9.68% |
Managers | Title | Age | Since |
---|---|---|---|
John Butler
CEO | Chief Executive Officer | 59 | 13-06-30 |
Tracey Vetterick
ADM | Chief Administrative Officer | - | 22-03-31 |
Michel Dahan
COO | Chief Operating Officer | 45 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Rogers
BRD | Director/Board Member | 64 | 18-12-11 |
Adrian Adams
CHM | Chairman | 73 | 18-12-11 |
LeAnne Zumwalt
BRD | Director/Board Member | 65 | 21-02-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.12 | +3.70% | 2,114,042 |
24-05-30 | 1.08 | +4.85% | 2,226,275 |
24-05-29 | 1.03 | -3.74% | 3,395,784 |
24-05-28 | 1.07 | -2.73% | 2,845,383 |
24-05-24 | 1.1 | +0.92% | 1,640,485 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.68% | 235M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- AKBA Stock